Characterization of Burkholderia rhizoxinica and B. endofungorum Isolated from Clinical Specimens
2011

Characterization of Burkholderia rhizoxinica and B. endofungorum from Clinical Specimens

Sample size: 8 publication Evidence: moderate

Author Information

Author(s): Gee Jay E., Glass Mindy B., Lackner Gerald, Helsel Leta O., Daneshvar Maryam, Hollis Dannie G., Jordan Jean, Morey Roger, Steigerwalt Arnold, Hertweck Christian

Primary Institution: Centers for Disease Control and Prevention

Hypothesis

The study aims to identify and characterize clinical isolates of Burkholderia rhizoxinica and B. endofungorum.

Conclusion

The study successfully identified seven clinical isolates as B. rhizoxinica and one as B. endofungorum, demonstrating their potential role in human infections.

Supporting Evidence

  • Eight clinical isolates were identified as members of the genus Burkholderia.
  • Seven isolates were identified as B. rhizoxinica and one as B. endofungorum.
  • The study assessed toxin production and characterized the isolates using multiple methods.

Takeaway

Scientists found bacteria in clinical samples that can make toxins, which might be important for understanding infections.

Methodology

The study used biochemical testing, 16S rRNA gene sequencing, and DNA-DNA hybridization to identify and characterize the isolates.

Limitations

Clinical records for the isolates were incomplete, and the possibility of contamination could not be excluded.

Participant Demographics

The isolates were derived from five adult males and three adult females.

Digital Object Identifier (DOI)

10.1371/journal.pone.0015731

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication